From the desk of Tom Bruni @BruniCharting

New Mystery Chart!

For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or relative basis. Maybe it's a custom index or inverted, who knows!

We do all this to put aside the biases we have associated with this specific security/the market and come to a conclusion based solely on price.

You can guess what it is if you must, but the real value comes from sharing what you would do right now. Buy, Sell, or Do Nothing?

The Nifty 50 and Nifty 500 are back at the top of their multi-year range right as we're starting to see signs of exhaustion in various global markets.

Failed breakouts and bearish momentum divergences help us to identify potential reversals in the market and we're seeing a few of them occur in India and elsewhere.

From the desk of Tom Bruni @BruniCharting

Over the weekend I was running our "Weekend Momentum Report" for Institutional Clients and the message was very similar to last week, so I thought it was worth sharing.

With a new month come fresh monthly candles.

While we were going to write a comprehensive post on the most important monthly charts from November, we realized there are only two that matter to India's stock market right now.

Let's take a look.

From the desk of Tom Bruni @BruniCharting

In this week's Chart of The Week, we discussed the lackluster rally attempt in international stocks relative to the S&P 500.

We concluded that the trend of underperformance remains firmly intact, which brings us to this week's mystery chart reveal.

Let's take a look.

Today we want to highlight a concerning development in the Nifty Realty sector and what it means for our approach to its components.

From the desk of Tom Bruni @BruniCharting

Since late August when interest rates around the globe began their counter-trend rally we've begun to see some outperformance from international equities...leading to headlines like this.

So, is the trend in international underperformance finally over?

Let's take a look.

Over the last few weeks, we've talked about potential long-term bottoms in weaker sectors like Nifty PSU Banks, Pharma, among others.

Today we're taking a look at the Nifty Media Index as it confirms a failed breakdown that could serve as the catalyst for a new move higher.

From the desk of Tom Bruni @BruniCharting

New Mystery Chart!

For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or relative basis. Maybe it's a custom index or inverted, who knows!

We do all this to put aside the biases we have associated with this specific security/the market and come to a conclusion based solely on price.

You can guess what it is if you must, but the real value comes from sharing what you would do right now. Buy, Sell, or Do Nothing?

From the desk of Tom Bruni @BruniCharting

Tuesday's Mystery Chart had a lot of people talking and guessing (incorrectly, as usual), so thank you all for your feedback and participation.

Overall the feedback was the chart was a longer-term buy, but people had concerns about how far it's run in the near-term.

With that as our backdrop, let's get into it.

Here's the US Healthcare Providers (IHF) which is emerging from a consolidation via a sharp rally as momentum gets overbought.

Overall this looks like the start of the subsector's next major move to the upside, but we'll get more information about its sustainability from seeing how prices digest their more than 20% gains since early October. Bulls want to see that correction occur through time, rather than price, with IHF preferably staying above its July highs near 180.

Click on chart to enlarge view.

In September we wrote about the Pharmaceuticals sector and its inability to gain traction due to relentless weakness in many components, particularly its largest component, Sun Pharmaceuticals.

Over the last two months the sector is basically flat, but several signs have emerged to suggest that we're potentially at a major inflection point.

With that as our backdrop, let's get into the charts.

This week's Chart of The Week outlined a compelling case for the Pharmaceutical sector to bottom at current levels, so this post is going to outline the stocks we want to be buying to capitalize on this potential inflection point.